Last reviewed · How we verify

NCT06924034

Early-phase Exercise-based Cardiac Rehabilitation After MI

Completed NA Last updated 11 April 2025
What this trial tests

NA trial testing Phase I and Phase II Cardiac Rehabilitation Program in Myocardial Infarction (MI) in 32 participants. Completed in 25 June 2024.

Timeline
3 July 2023
Primary endpoint
31 May 2024
25 June 2024

Quick facts

Lead sponsorDokuz Eylul University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment32
Start date3 July 2023
Primary completion31 May 2024
Estimated completion25 June 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Dokuz Eylul University

Who can join

Adults 30 to 65, any sex, with Myocardial Infarction (MI). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to investigate the effects of early-phase exercise-based supervised cardiac rehabilitation on functional exercise capacity, grip strength, fatigue, sleep quality, and health-related quality of life.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Early-Phase Exercise-Based Comprehensive Cardiac Rehabilitation Program after Myocardial Infarction: A Randomized Controlled Trial.
    Ocaker Aktan Ö, Özalevli S, Dursun H, Başkurt AA, et al · · 2026 · PMID 41608270 · DOI 10.6515/acs.202601_42(1).20250714d

Verify or expand the search:

Other recruiting trials for Myocardial Infarction (MI)

Currently open trials in the same condition.

Other Dokuz Eylul University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06924034.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing